Melanie E. Fields

Melanie E. Fields

Auto-generated profile, based on publicly available information

Melanie E. Fields

Department of Pediatrics Washington University School of Medicine St. Louis Missouri USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 May 2019 in Blood
Verified
Journal Article
Open access
PDF file
MFMelanie E. Fields
Melanie E. Fields
KGKristin P. Guilliams
Kristin P. Guilliams
DRDustin Ragan
Dustin Ragan
MBMichael M. Binkley
Michael M. Binkley
AMAmy Mirro
Amy Mirro
AFAndria L. Ford
Andria L. Ford
Chronic transfusion therapy (CTT) prevents stroke in selected patients with sickle cell anemia (SCA). We have shown that CTT mitigates signatures of cerebral metabolic stress, reflected by elevated oxygen extraction fraction (OEF), which likely drives stroke risk reduction. The region of highest OEF falls within the border zone, where cerebral blood flow (CBF) nadirs; OEF in this region was reduced after CTT. The neuroprotective efficacy of hydroxyurea (HU) remains unclear. To test our hypothesis that patients receiving HU therapy have lower cerebral metabolic stress compared with patients not receiving disease-modifying therapy, we prospectively obtained brain magnetic resonance imaging scans with voxel-wise measurements of CBF and OEF in 84 participants with SCA who were grouped by therapy: no disease-modifying therapy, HU, or CTT. There was no difference in whole-brain CBF among the 3 cohorts (P = .148). However, whole-brain OEF was significantly different (P < .001): participants without disease-modifying therapy had the highest OEF (median 42.9% [interquartile range (IQR) 39.1%-49.1%]), followed by HU treatment (median 40.7% [IQR 34.9%-43.6%]), whereas CTT treatment had the lowest values (median 35.3% [IQR 32.2%-38.9%]). Moreover, the percentage of white matter at highest risk for ischemia, defined by OEF greater than 40% and 42.5%, was lower in the HU cohort compared with the untreated cohort (P = .025 and P = .034 respectively), but higher compared with the CTT cohort (P = .018 and P = .029 respectively). We conclude that HU may offer neuroprotection by mitigating cerebral metabolic stress in patients with SCA, but not to the same degree as CTT.

26 January 2023 in Blood
Verified
Journal Article
Open access
PDF file
MHMonica L. Hulbert
Monica L. Hulbert
MFMelanie E. Fields
Melanie E. Fields
KGKristin P. Guilliams
Kristin P. Guilliams
PBPriyesha Bijlani
Priyesha Bijlani
SSShalini Shenoy
Shalini Shenoy
AFAndria L. Ford
Andria L. Ford
Children with sickle cell disease (SCD) demonstrate cerebral hemodynamic stress and are at high risk of strokes. We hypothesized that curative hematopoietic stem cell transplant (HSCT) normalizes cerebral hemodynamics in children with SCD compared with pre-transplant baseline. Whole-brain cerebral blood flow (CBF) and oxygen extraction fraction (OEF) were measured by magnetic resonance imaging 1 to 3 months before and 12 to 24 months after HSCT in 10 children with SCD. Three children had prior overt strokes, 5 children had prior silent strokes, and 1 child had abnormal transcranial Doppler ultrasound velocities. CBF and OEF of HSCT recipients were compared with non-SCD control participants and with SCD participants receiving chronic red blood cell transfusion therapy (CRTT) before and after a scheduled transfusion. Seven participants received matched sibling donor HSCT, and 3 participants received 8 out of 8 matched unrelated donor HSCT. All received reduced-intensity preparation and maintained engraftment, free of hemolytic anemia and SCD symptoms. Pre-transplant, CBF (93.5 mL/100 g/min) and OEF (36.8%) were elevated compared with non-SCD control participants, declining significantly 1 to 2 years after HSCT (CBF, 72.7 mL/100 g per minute; P = .004; OEF, 27.0%; P = .002), with post-HSCT CBF and OEF similar to non-SCD control participants. Furthermore, HSCT recipients demonstrated greater reduction in CBF (−19.4 mL/100 g/min) and OEF (−8.1%) after HSCT than children with SCD receiving CRTT after a scheduled transfusion (CBF, −0.9 mL/100 g/min; P = .024; OEF, −3.3%; P = .001). Curative HSCT normalizes whole-brain hemodynamics in children with SCD. This restoration of cerebral oxygen reserve may explain stroke protection after HSCT in this high-risk patient population.

14 February 2022 in American Journal of Hematology
Verified
Journal Article
Closed access
PDF file
MFMelanie E. Fields
Melanie E. Fields
AMAmy E. Mirro
Amy E. Mirro
MBMichael M. Binkley
Michael M. Binkley
KGKristin P. Guilliams
Kristin P. Guilliams
JLJosiah B. Lewis
Josiah B. Lewis
JLJin‐Moo Lee
Jin‐Moo Lee

16 September 2020 in Annals of Neurology
Verified
Journal Article
Closed access
PDF file
MFMelanie E. Fields
Melanie E. Fields
AMAmy E. Mirro
Amy E. Mirro
KGKristin P. Guilliams
Kristin P. Guilliams
MBMichael M. Binkley
Michael M. Binkley
LDLuisa Gil Diaz
Luisa Gil Diaz
JLJin‐Moo Lee
Jin‐Moo Lee

19 April 2022 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
AOAmy Ouyang
Amy Ouyang
MGManasa Gadiraju
Manasa Gadiraju
VGVeda Gadiraju
Veda Gadiraju
LPLandon Power
Landon Power
VGVinitha Gadiraju
Vinitha Gadiraju
MFMelanie E. Fields
Melanie E. Fields

1 September 2022 in Stroke
Verified
Journal Article
Closed access
PDF file
YWYan Wang
Yan Wang
KGKristin P. Guilliams
Kristin P. Guilliams
MFMelanie E. Fields
Melanie E. Fields
SFSlim Fellah
Slim Fellah
MBMichael M. Binkley
Michael M. Binkley
AFAndria L. Ford
Andria L. Ford
Background: Individuals with sickle cell anemia have heightened risk of stroke and cognitive dysfunction. Given its high prevalence globally, whether sickle cell trait (SCT) is a risk factor for neurological injury has been of interest; however, data have been limited. We hypothesized that young, healthy adults with SCT would show normal cerebrovascular structure and hemodynamic function. Methods: As a case-control study, young adults with (N=25, cases) and without SCT (N=24, controls) underwent brain magnetic resonance imaging to quantify brain volume, microstructural integrity (fractional anisotropy), silent cerebral infarcts (SCI), intracranial stenosis, and aneurysms. Pseudocontinuous arterial spin labeling and asymmetric spin echo sequences measured cerebral blood flow and oxygen extraction fraction, respectively, from which cerebral metabolic oxygen demand was calculated. Imaging metrics were compared between SCT cases and controls. SCI volume was correlated with baseline characteristics. Results: Compared with controls, adults with SCT demonstrated similar normalized brain volumes (SCT 0.80 versus control 0.81, P =0.41), white matter fractional anisotropy (SCT 0.41 versus control 0.43, P =0.37), cerebral blood flow (SCT 62.04 versus control, 61.16 mL/min/100 g, P =0.67), oxygen extraction fraction (SCT 0.27 versus control 0.27, P =0.31), and cerebral metabolic oxygen demand (SCT 2.71 versus control 2.70 mL/min/100 g, P =0.96). One per cohort had an intracranial aneurysm. None had intracranial stenosis. The SCT cases and controls showed similar prevalence and volume of SCIs; however, in the subset of participants with SCIs, the SCT cases had greater SCI volume versus controls (0.29 versus 0.07 mL, P =0.008). Of baseline characteristics, creatinine was mildly elevated in the SCT cohort (0.9 versus 0.8 mg/dL, P =0.053) and correlated with SCI volume (ρ=0.49, P =0.032). In the SCT cohort, SCI distribution was similar to that of young adults with sickle cell anemia. Conclusions: Adults with SCT showed normal cerebrovascular structure and hemodynamic function. These findings suggest that healthy individuals with SCT are unlikely to be at increased risk for early or accelerated ischemic brain injury.